Term ends Oct 25, 2033 · Medium confidence
20-year base term ends Nov 1, 2033
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 8,877,197), so the cap could be lower.
Nov 1, 2013
Oct 25, 2033
Feb 7, 2017
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 2 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 1, 2013, when application 14/070,186, the earliest non-provisional in its chain, was filed (this one was filed Nov 4, 2015) | Nov 1, 2033 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,877,197, US 8,945,562, US 9,074,003, US 9,074,004, US 9,206,259, US 9,512,233) | capped to Oct 25, 2033 | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 25, 2033 | Medium confidence |
This family
| US 8,945,562 | In force Nov 2033 | Nov 2033 |
| US 8,877,197 | In force no later than Feb 2036 | no later than Feb 2036 |
| US 9,074,003 | In force Nov 2033 | Nov 2033 |
| US 9,074,004 | In force Nov 2033 | Nov 2033 |
| US 9,206,259 | In force Nov 2033 | Nov 2033 |
| US 9,562,092 | this patent Oct 2033 | Oct 2033 |
| US 10,450,382 | In force Nov 2033 | Nov 2033 |
| Application 16/561,202 | Abandoned not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 9, 2016 Reel 37932, frame 589 | Van Vlasselaer, Peter; Parry, Graham; Stagliano, Nancy E.; Panicker, Sandip | True North Therapeutics, Inc. | Assignment of Assignor's Interest |
| Oct 4, 2017 Reel 44126, frame 710 | True North Therapeutics, Inc. | Bioverativ USA Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 8,877,197, US 8,945,562, US 9,074,003, US 9,074,004, US 9,206,259, US 9,512,233.